STOCKHOLDERS' EQUITY - Stock Options (Details) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2023 USD ($) tranche $ / shares shares	Dec. 31, 2021 $ / shares	Dec. 31, 2022 shares
Stock-based compensation
Outstanding common stock (in shares) | shares	132,822
Number of tranches | tranche	3
Weighted average exercise price | $ / shares	$ 28.32
Options exercisable | shares	0		0
Outstanding at the end of the period	3 years 1 month 6 days
Tranche One
Stock-based compensation
Outstanding common stock (in shares) | shares	44,274
Weighted average exercise price | $ / shares	$ 18.91
Tranche Two
Stock-based compensation
Outstanding common stock (in shares) | shares	44,274
Weighted average exercise price | $ / shares	$ 28.23
Tranche Three
Stock-based compensation
Outstanding common stock (in shares) | shares	44,274
Weighted average exercise price | $ / shares	$ 37.83
Stock options
Stock-based compensation
Weighted average grant date fair value of grants | $ / shares		$ 3.36
2020 Incentive Plan | Stock options
Stock-based compensation
Vesting period	4 years
Percentage of awards vesting on the annual anniversary date of the grant	0.25
Expiration term	7 years
Unrecognized compensation expense stock option | $	$ 0.1
Weighted average remaining vesting period	1 month 6 days